Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy

Area of Science:

• Cancer Biology
• Immunology
• Nanotechnology
• Metabolic Engineering

Background:

• Tumor cells exhibit altered metabolic profiles due to mutation burden, hypoxia, and immunoediting.
• These metabolic changes create a tumor microenvironment (TME) with toxic metabolites and nutrient depletion, suppressing antitumor immunity.
• This immunosuppression significantly hinders the efficacy of current tumor immunotherapies.

Purpose of the Study:

• To review recent advances in understanding tumor cell metabolism's role in cancer immunoevasion and immunosuppression.
• To discuss nanotechnology-based metabolic reprogramming strategies for enhancing tumor immunotherapies.
• To highlight the potential of targeting tumor metabolism for effective cancer treatment.

Main Methods:

• Comprehensive literature review of studies on tumor metabolism, immunoevasion, and immunotherapy.
• Analysis of mechanisms by which tumor metabolism affects the tumor microenvironment and immune cells.
• Exploration of nanotechnology applications in modulating tumor cell metabolism and boosting immunometabolic therapies.

Main Results:

• Tumor metabolic reprogramming is a key mechanism for cancer cells to evade immune surveillance and suppress anti-tumor immune responses.
• Metabolism-targeting drugs face challenges including off-target toxicity and side effects, limiting their therapeutic application.
• Nanotechnologies show promise for targeted delivery and precise metabolism modulation within the TME.

Conclusions:

• Understanding tumor cell metabolism is crucial for developing novel anti-cancer drugs and therapies.
• Nanotechnology-based strategies offer a promising avenue for metabolic reprogramming to overcome immunotherapy resistance.
• Targeting tumor metabolism with nanotech-enabled approaches can significantly enhance anti-tumor immunity and improve therapeutic outcomes.